Literature DB >> 16672151

Pathogenesis of salt sensitivity of blood pressure.

Myron H Weinberger1.   

Abstract

The effect of sodium in human blood pressure has been a contentious subject of considerable debate for decades. Nonetheless, it is generally conceded that there is heterogeneity to alterations in sodium and extracellular fluid volume in the blood pressure responses of normal and hypertensive humans. Although there are many forms of experimental and clinical hypertension that are clearly related to abnormalities of sodium handling and metabolism, it has been only the advent of the genetic revolution that has provided critical new insight into the mechanisms involved in many of these conditions. In this review, the clinical manifestations of salt sensitivity and several clinical syndromes associated with abnormal sodium metabolism are discussed, and factors that appear to be involved in many of the clinical abnormalities as well as relevant new insights derived from basic research are elucidated.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16672151     DOI: 10.1007/s11906-006-0014-y

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  42 in total

1.  sgk is an aldosterone-induced kinase in the renal collecting duct. Effects on epithelial na+ channels.

Authors:  A Náray-Fejes-Tóth; C Canessa; E S Cleaveland; G Aldrich; G Fejes-Tóth
Journal:  J Biol Chem       Date:  1999-06-11       Impact factor: 5.157

2.  Hyperplasia of the juxtaglomerular complex with hyperaldosteronism and hypokalemic alkalosis. A new syndrome.

Authors:  F C BARTTER; P PRONOVE; J R GILL; R C MACCARDLE
Journal:  Am J Med       Date:  1962-12       Impact factor: 4.965

3.  Salt sensitivity, pulse pressure, and death in normal and hypertensive humans.

Authors:  M H Weinberger; N S Fineberg; S E Fineberg; M Weinberger
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

Review 4.  Vascular endothelin in hypertension.

Authors:  Ernesto L Schiffrin
Journal:  Vascul Pharmacol       Date:  2005-06       Impact factor: 5.773

5.  The effect of high-sodium and low-sodium intakes on blood pressure and other related variables in human subjects with idiopathic hypertension.

Authors:  T Kawasaki; C S Delea; F C Bartter; H Smith
Journal:  Am J Med       Date:  1978-02       Impact factor: 4.965

6.  Definitions and characteristics of sodium sensitivity and blood pressure resistance.

Authors:  M H Weinberger; J Z Miller; F C Luft; C E Grim; N S Fineberg
Journal:  Hypertension       Date:  1986-06       Impact factor: 10.190

7.  Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter.

Authors:  D B Simon; C Nelson-Williams; M J Bia; D Ellison; F E Karet; A M Molina; I Vaara; F Iwata; H M Cushner; M Koolen; F J Gainza; H J Gitleman; R P Lifton
Journal:  Nat Genet       Date:  1996-01       Impact factor: 38.330

8.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

9.  Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes.

Authors:  A Bettinelli; M G Bianchetti; E Girardin; A Caringella; M Cecconi; A C Appiani; L Pavanello; R Gastaldi; C Isimbaldi; G Lama
Journal:  J Pediatr       Date:  1992-01       Impact factor: 4.406

Review 10.  Salt sensitivity of blood pressure in humans.

Authors:  M H Weinberger
Journal:  Hypertension       Date:  1996-03       Impact factor: 10.190

View more
  21 in total

Review 1.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 2.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

3.  Impact of breathing awareness meditation on ambulatory blood pressure and sodium handling in prehypertensive African American adolescents.

Authors:  Vernon A Barnes; Robert A Pendergrast; Gregory A Harshfield; Frank A Treiber
Journal:  Ethn Dis       Date:  2008       Impact factor: 1.847

Review 4.  Excess dietary salt intake alters the excitability of central sympathetic networks.

Authors:  Sean D Stocker; Christopher J Madden; Alan F Sved
Journal:  Physiol Behav       Date:  2010-05-01

5.  Vascular Type 1A Angiotensin II Receptors Control BP by Regulating Renal Blood Flow and Urinary Sodium Excretion.

Authors:  Matthew A Sparks; Johannes Stegbauer; Daian Chen; Jose A Gomez; Robert C Griffiths; Hooman A Azad; Marcela Herrera; Susan B Gurley; Thomas M Coffman
Journal:  J Am Soc Nephrol       Date:  2015-04-08       Impact factor: 10.121

Review 6.  Neurogenic and sympathoexcitatory actions of NaCl in hypertension.

Authors:  Sean D Stocker; Kevin D Monahan; Kirsteen N Browning
Journal:  Curr Hypertens Rep       Date:  2013-12       Impact factor: 5.369

7.  Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension.

Authors:  Paolo Manunta; John M Hamlyn; Marco Simonini; Elisabetta Messaggio; Chiara Lanzani; Maria Bracale; Giuseppe Argiolas; Nunzia Casamassima; Elena Brioni; Nicola Glorioso; Giuseppe Bianchi
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

Review 8.  Stress-induced sodium retention and hypertension: a review and hypothesis.

Authors:  Gregory A Harshfield; Yanbin Dong; Gaston K Kapuku; Haidong Zhu; Coral D Hanevold
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

9.  Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter.

Authors:  Robert M Carey; Cynthia D Schoeffel; John J Gildea; John E Jones; Helen E McGrath; Lindsay N Gordon; Min Jeong Park; Rafal S Sobota; Patricia C Underwood; Jonathan Williams; Bei Sun; Benjamin Raby; Jessica Lasky-Su; Paul N Hopkins; Gail K Adler; Scott M Williams; Pedro A Jose; Robin A Felder
Journal:  Hypertension       Date:  2012-09-17       Impact factor: 10.190

10.  Orally active epoxyeicosatrienoic acid analog attenuates kidney injury in hypertensive Dahl salt-sensitive rat.

Authors:  Md Abdul Hye Khan; Jan Neckár; Vijay Manthati; Ramu Errabelli; Tengis S Pavlov; Alexander Staruschenko; John R Falck; John D Imig
Journal:  Hypertension       Date:  2013-08-26       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.